Foundation Medicine, Inc.
23.37-0.09 (-0.38%)

After hours: 23.37-0.00 (-0.02%) as of 4:46 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close23.46
Bid22.00 x 100
Ask32.44 x 100
52wk Range13.34 - 25.98
Day's Range23.10 - 23.89
Avg Vol (3m)223,760
As of 4:00 PM EDT. Market closed.
  • American City Business Journalslast month

    Cambridge diagnostic firm to double size of 'Moonshot' cancer database

    The National Cancer Institute’s ability to match up differences in a person’s genes with the exact types of cancer most likely to affect them — also indicating which drugs would be most effective — will soon be dramatically increased thanks to the Cambridge diagnostic firm Foundation Medicine. The Genomic Data Commons, or GDC, was launched by Vice President Joe Biden at the annual meeting of the American Society of Clinical Oncologists on June 6 . The GDC is a database of genomic profiles of people with cancer, allowing for a big data approach to differentiating between the hundreds of types of cancer, and is a key piece of President Barack Obama’s Cancer Moonshot announced early this year, as well as his Precision Medicine Initiative that was announced last year.

  • Forbeslast month

    Foundation Medicine On Biden's Cancer Moonshot: A 'Pep Rally' Can't Hurt

    Foundation Medicine CEO Michael Pellini will be participating in a series of Cancer Moonshot events across the country today. Vice President Biden's efforts to accelerate cancer research are important, he says, but there are major challenges to overcome.